Teva Pharma shares jump 17% on pending agreement over opioid litigation
Teva Pharmaceutical Industries Ltd. American depositary receipts jumped 17% to $8.31 in after-hours trading Tuesday…
Read MoreTeva Pharmaceutical Industries Ltd. American depositary receipts jumped 17% to $8.31 in after-hours trading Tuesday…
Read More
Opinion: The opioid epidemic is costing us $1.5 trillion a year. And we’re spending peanuts to fight it.
The U.S. economy is being battered on all sides: Inflation, snarled supply chains, severe labor…
Read More